Our study aims to evaluate BRAF mutation in different MM subtypes and to correlate the evidence of the mutation with clinicopathological parameters, highlighting BRAF mutation frequency differences in primary versus metastatic MM. The gene discussed is BRAF; the disease is Miyoshi myopathy.